에스디바이오센서: management transactions · South Korea · DART (FSS) DART:company-fa7559 KR KR · DART (FSS) Mcap 949.8Bn€ Healthcare
Browse the full management transaction log of 에스디바이오센서, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 에스디바이오센서 has recorded 12 reports. Market capitalisation: €949.8bn. The latest transaction was filed on 24 March 2026 — Purchase. Among the most active insiders: 조영식. All data is openly available.
Financial data FY ended December 2025 · cache
Income statement
Revenue 710.58 Bn€
Gross profit 325.53 Bn€ 46% margin
Net income −512.11 Bn€ -72.1% margin
Balance sheet & cash
Market cap 949.78 Bn€
Total debt 669.03 Bn€
Free Cash Flow 300.03 Bn€
Debt / Equity 29%
Profitability & ownership
ROE -19.5%
ROA -1.5%
% insiders 72.6%
% institutions 2.5%
Last declaration on 24 March 2026
Declarations 12 total
Executives ● Purchase9 DART
DART:20260324000829 · 24 Mar 2026
Ideal exit: 19 Dec 2026 (T+270) Executives ● Purchase9 DART
DART:20260324000786 · 24 Mar 2026
Ideal exit: 19 Dec 2026 (T+270) Executives ● Purchase9 DART
DART:20260324000803 · 24 Mar 2026
Ideal exit: 19 Dec 2026 (T+270) Executives ● Purchase9 DART
DART:20260324000790 · 24 Mar 2026
Ideal exit: 19 Dec 2026 (T+270) Executives ● Purchase9 DART
DART:20260324000777 · 24 Mar 2026
Ideal exit: 19 Dec 2026 (T+270) Executives ● Purchase9 DART
DART:20260324000810 · 24 Mar 2026
Ideal exit: 19 Dec 2026 (T+270) Executives ● Purchase13 DART
DART:20260324000736 · 24 Mar 2026
Ideal exit: 19 Dec 2026 (T+270) Executives ● Purchase13 DART
DART:20260324000683 · 24 Mar 2026
Ideal exit: 19 Dec 2026 (T+270) Executives ● Purchase13 DART
DART:20260324000758 · 24 Mar 2026
Ideal exit: 19 Dec 2026 (T+270) Executives ● Purchase9 DART
DART:20260324000823 · 24 Mar 2026
Ideal exit: 19 Dec 2026 (T+270) Executives ● Other4 DART
0
DART:20260319000920 · 19 Mar 2026
Executives ● Purchase4 DART
€1m 299,549 shares
DART:20260316000452 · 16 Mar 2026
Ideal exit: 11 Dec 2026 (T+270)